Justin Kline, MD, discussed CD5 gene expression signature as a useful biomarker to identify diffuse large B-cell lymphoma subtypes vulnerable to BTK inhibitor therapies.
Justin Kline, MD, discussed CD5 gene expression signature as a useful biomarker to identify diffuse large B-cell lymphoma subtypes vulnerable to BTK inhibitor therapies.
Justin Kline, MD, discussed CD5...